查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1922459

日本荷爾蒙補充療法市場報告：按產品、給藥途徑、疾病類型和地區分類（2026-2034年）

Japan Hormone Replacement Therapy Market Report by Product, Route of Administration, Type of Disease, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 116 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

2025年，日本荷爾蒙補充療法市場規模達6.052億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到10.698億美元，2026年至2034年的複合年成長率（CAGR）為6.53%。推動該行業發展的關鍵因素包括：激素紊亂症發病率的上升、技術的顯著進步、給藥技術的持續創新以及政府的支持計劃和報銷政策。

荷爾蒙補充療法（HRT）是一種用於解決個別荷爾蒙失衡問題的醫療保健方法。該治療方法透過服用外源性荷爾蒙來補充或取代人體自身產生的荷爾蒙。醫療保健提供者（通常是內分泌科醫生或婦科醫生）會在對患者的病歷和症狀進行全面評估後，開立HRT處方。 HRT的目標是透過持續補充控制劑量的荷爾蒙來緩解與荷爾蒙缺乏或波動相關的症狀。在治療期間，醫生會密切監測荷爾蒙水平，以確保其維持在理想範圍內，從而促進整體健康並減少荷爾蒙失衡帶來的負面影響。

日本荷爾蒙補充療法市場的發展趨勢：

由於多種因素與全球醫療保健趨勢相符，日本的荷爾蒙補充療法市場正經歷顯著成長。其中一個關鍵促進因素是荷爾蒙失衡及相關疾病的日益增多。由於久坐不動的生活方式、壓力和老齡化等因素，這些疾病在人群中的發病率不斷上升。這些因素導致人們對荷爾蒙補充療法等治療性介入的需求日益成長。此外，患者和醫療專業人員對荷爾蒙替代療法作為一種有效治療選擇的認知度和接受度不斷提高，也促進了市場擴張。這種認知度的提升正在推動日本市場的發展。日本人口老化也是一個重要的促進因素。隨著老齡化，荷爾蒙失衡的發生率越來越高，老年人對荷爾蒙替代療法的需求也不斷增加。此外，荷爾蒙輸送方式（例如經皮吸收貼片和植入式裝置）的持續技術進步，使得荷爾蒙替代療法的給藥更加便捷和精準。這提高了患者的依從性，改善了治療效果，從而進一步推動了市場成長。此外，政府為幫助患者以可負擔的價格獲得激素替代療法而推出的各項舉措以及優惠的報銷政策，也為市場擴張創造了有利環境。這些因素綜合起來表明，在預測期內，日本荷爾蒙補充療法市場在解決荷爾蒙失衡及相關健康問題方面的重要性和潛力將會增加。

本報告解答的關鍵問題

  • 日本荷爾蒙補充療法市場目前發展狀況如何？您認為未來幾年該市場會如何發展？
  • 新冠疫情對日本荷爾蒙補充療法市場產生了哪些影響？
  • 日本荷爾蒙補充療法市場的產品組成是什麼？
  • 日本荷爾蒙補充療法市場按給藥途徑分類的情況如何？
  • 日本荷爾蒙補充療法市場按疾病類型分類的組成是怎樣的？
  • 請介紹日本荷爾蒙補充療法市場價值鏈的各個環節。
  • 日本荷爾蒙補充療法的主要促進因素和挑戰是什麼？
  • 日本荷爾蒙補充療法市場的結構是怎麼樣的？主要參與者有哪些？
  • 日本荷爾蒙補充療法市場競爭程度如何？

目錄

第1章：序言

第2章：調查範圍與調查方法

  • 調查目標
  • 相關利益者
  • 數據來源
  • 市場估值
  • 調查方法

第3章執行摘要

第4章：日本荷爾蒙補充療法市場－簡介

  • 概述
  • 市場動態
  • 產業趨勢
  • 競爭資訊

第5章 日本荷爾蒙補充療法市場概覽

  • 過去和當前的市場趨勢（2020-2025）
  • 市場預測（2026-2034）

第6章 日本荷爾蒙補充療法市場－依產品細分

  • 雌激素替代療法
  • 人體生長荷爾蒙替代療法
  • 甲狀腺替代療法
  • 睾酮替代療法
  • 其他

第7章：日本荷爾蒙補充療法市場－依給藥途徑細分

  • 口服
  • 注射
  • 經皮

第8章：日本荷爾蒙補充療法市場－依疾病類型細分

  • 更年期症狀
  • 甲狀腺機能低下症
  • 男性性腺功能低下症
  • 生長激素缺乏症
  • 其他

第9章：日本荷爾蒙補充療法市場：按地區分類

  • 關東地區
  • 關西、近畿地區
  • 中部地區
  • 九州和沖繩地區
  • 東北部地區
  • 中國地區
  • 北海道地區
  • 四國地區

第10章：日本荷爾蒙補充療法市場的競爭格局

  • 概述
  • 市場結構
  • 市場公司定位
  • 關鍵成功策略
  • 競爭對手儀錶板
  • 企業估值象限

第11章主要企業概況

第12章：日本荷爾蒙補充療法市場：產業分析

  • 促進因素、限制因素和機遇
  • 波特五力分析
  • 價值鏈分析

第13章附錄

簡介目錄
Product Code: SR112026A19204

Japan hormone replacement therapy market size reached USD 605.2 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,069.8 Million by 2034, exhibiting a growth rate (CAGR) of 6.53% during 2026-2034. The industry is experiencing growth due to several key drivers, including the increasing incidence of hormonal disorders, notable technological advancements, continuous innovations in delivery techniques, and supportive government programs and reimbursement policies.

Access the full market insights report Request Sample

Hormone replacement therapy (HRT) is a medical approach employed to address hormonal imbalances in individuals. This treatment involves the administration of external hormones to supplement or substitute the natural hormones produced by the body. Typically, healthcare providers, such as endocrinologists or gynecologists, prescribe HRT after a comprehensive assessment of the patient's medical history and symptoms. HRT's objective is to alleviate symptoms related to hormonal deficiencies or variations by consistently delivering controlled hormone doses. The treatment undergoes careful monitoring to ensure that hormone levels remain within the desired range, promoting overall well-being and potentially mitigating the negative effects of hormonal imbalances.

JAPAN HORMONE REPLACEMENT THERAPY MARKET TRENDS:

The Japan hormone replacement therapy market is experiencing substantial growth, driven by a combination of factors that align with global healthcare trends. A key driver is the increasing prevalence of hormonal imbalances and related disorders, which are becoming more prevalent in the population due to factors like sedentary lifestyles, stress, and the natural process of aging. These factors have created a growing need for therapeutic interventions such as hormone replacement therapy. Furthermore, the market benefits from the rising awareness and acceptance of HRT as an effective treatment option among both patients and healthcare professionals. This increasing recognition has contributed to the expansion of the market in Japan. The aging demographic in Japan is another significant driver, as hormonal imbalances become more common with age. This demographic shift has led to a higher demand for HRT among the elderly population. Moreover, ongoing technological advancements in hormone delivery methods, such as transdermal patches and implantable devices, are making HRT more convenient and targeted in its administration. This enhances patient compliance and improves treatment outcomes, further fueling market growth. Additionally, supportive government initiatives and favorable reimbursement policies aimed at ensuring affordable access to HRT for patients are creating favorable conditions for market expansion. These collective factors will underscore the growing importance and potential of the Japan hormone replacement therapy market in addressing hormonal imbalances and related health concerns over the forecasted period.

JAPAN HORMONE REPLACEMENT THERAPY MARKET SEGMENTATION:

Product Insights:

  • To get detailed segment analysis of this market Request Sample
  • Estrogen Replacement Therapy
  • Human Growth Hormone Replacement Therapy
  • Thyroid Replacement Therapy
  • Testosterone Replacement Therapy
  • Others
  • Estrogen Replacement Therapy
  • Human Growth Hormone Replacement Therapy
  • Thyroid Replacement Therapy
  • Testosterone Replacement Therapy
  • Others

Route of Administration Insights:

  • Oral
  • Parenteral
  • Transdermal
  • Oral
  • Parenteral
  • Transdermal

Type of Disease Insights:

  • Menopause
  • Hypothyroidism
  • Male Hypogonadism
  • Growth Hormone Deficiency
  • Others
  • Menopause
  • Hypothyroidism
  • Male Hypogonadism
  • Growth Hormone Deficiency
  • Others

Regional Insights:

  • To get detailed regional analysis of this market Request Sample
  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

  • KEY QUESTIONS ANSWERED IN THIS REPORT
  • How has the Japan hormone replacement therapy market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan hormone replacement therapy market?
  • What is the breakup of the Japan hormone replacement therapy market on the basis of product?
  • What is the breakup of the Japan hormone replacement therapy market on the basis of route of administration?
  • What is the breakup of the Japan hormone replacement therapy market on the basis of type of disease?
  • What are the various stages in the value chain of the Japan hormone replacement therapy market?
  • What are the key driving factors and challenges in the Japan hormone replacement therapy?
  • What is the structure of the Japan hormone replacement therapy market and who are the key players?
  • What is the degree of competition in the Japan hormone replacement therapy market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Hormone Replacement Therapy Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Hormone Replacement Therapy Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Hormone Replacement Therapy Market - Breakup by Product

  • 6.1 Estrogen Replacement Therapy
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Human Growth Hormone Replacement Therapy
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)
  • 6.3 Thyroid Replacement Therapy
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Forecast (2026-2034)
  • 6.4 Testosterone Replacement Therapy
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2020-2025)
    • 6.4.3 Market Forecast (2026-2034)
  • 6.5 Others
    • 6.5.1 Historical and Current Market Trends (2020-2025)
    • 6.5.2 Market Forecast (2026-2034)

7 Japan Hormone Replacement Therapy Market - Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Parenteral
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Transdermal
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)

8 Japan Hormone Replacement Therapy Market - Breakup by Type of Disease

  • 8.1 Menopause
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Hypothyroidism
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)
  • 8.3 Male Hypogonadism
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Forecast (2026-2034)
  • 8.4 Growth Hormone Deficiency
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2020-2025)
    • 8.4.3 Market Forecast (2026-2034)
  • 8.5 Others
    • 8.5.1 Historical and Current Market Trends (2020-2025)
    • 8.5.2 Market Forecast (2026-2034)

9 Japan Hormone Replacement Therapy Market - Breakup by Region

  • 9.1 Kanto Region
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Breakup by Product
    • 9.1.4 Market Breakup by Route of Administration
    • 9.1.5 Market Breakup by Type of Disease
    • 9.1.6 Key Players
    • 9.1.7 Market Forecast (2026-2034)
  • 9.2 Kansai/Kinki Region
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Breakup by Product
    • 9.2.4 Market Breakup by Route of Administration
    • 9.2.5 Market Breakup by Type of Disease
    • 9.2.6 Key Players
    • 9.2.7 Market Forecast (2026-2034)
  • 9.3 Central/ Chubu Region
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2020-2025)
    • 9.3.3 Market Breakup by Product
    • 9.3.4 Market Breakup by Route of Administration
    • 9.3.5 Market Breakup by Type of Disease
    • 9.3.6 Key Players
    • 9.3.7 Market Forecast (2026-2034)
  • 9.4 Kyushu-Okinawa Region
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2020-2025)
    • 9.4.3 Market Breakup by Product
    • 9.4.4 Market Breakup by Route of Administration
    • 9.4.5 Market Breakup by Type of Disease
    • 9.4.6 Key Players
    • 9.4.7 Market Forecast (2026-2034)
  • 9.5 Tohoku Region
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2020-2025)
    • 9.5.3 Market Breakup by Product
    • 9.5.4 Market Breakup by Route of Administration
    • 9.5.5 Market Breakup by Type of Disease
    • 9.5.6 Key Players
    • 9.5.7 Market Forecast (2026-2034)
  • 9.6 Chugoku Region
    • 9.6.1 Overview
    • 9.6.2 Historical and Current Market Trends (2020-2025)
    • 9.6.3 Market Breakup by Product
    • 9.6.4 Market Breakup by Route of Administration
    • 9.6.5 Market Breakup by Type of Disease
    • 9.6.6 Key Players
    • 9.6.7 Market Forecast (2026-2034)
  • 9.7 Hokkaido Region
    • 9.7.1 Overview
    • 9.7.2 Historical and Current Market Trends (2020-2025)
    • 9.7.3 Market Breakup by Product
    • 9.7.4 Market Breakup by Route of Administration
    • 9.7.5 Market Breakup by Type of Disease
    • 9.7.6 Key Players
    • 9.7.7 Market Forecast (2026-2034)
  • 9.8 Shikoku Region
    • 9.8.1 Overview
    • 9.8.2 Historical and Current Market Trends (2020-2025)
    • 9.8.3 Market Breakup by Product
    • 9.8.4 Market Breakup by Route of Administration
    • 9.8.5 Market Breakup by Type of Disease
    • 9.8.6 Key Players
    • 9.8.7 Market Forecast (2026-2034)

10 Japan Hormone Replacement Therapy Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Product Portfolio
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Product Portfolio
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Product Portfolio
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Product Portfolio
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Product Portfolio
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

12 Japan Hormone Replacement Therapy Market - Industry Analysis

  • 12.1 Drivers, Restraints, and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix